IsoPlexis Corp
NASDAQ:ISO
IsoPlexis Corp
NASDAQ:ISO
Price:
0.7616 USD
Market Closed
Updated:
May 1, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of ISO.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ISO
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
ISO Competitors Multiples
IsoPlexis Corp Competitors
IsoPlexis Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
IsoPlexis Corp
NASDAQ:ISO
|
30.2m USD | 1.8 | -0.3 | -0.4 | -0.4 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.5B USD | 5.2 | 36.9 | 22.8 | 33.4 | |
| US |
|
Danaher Corp
NYSE:DHR
|
182B USD | 4.2 | 22.6 | 16.4 | 20.2 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.9B USD | 2.8 | 30.9 | 16.8 | 25.9 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
40.4B USD | 6 | 32.7 | 26.1 | 31.4 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 15 | 64.8 | 34.2 | 49.2 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.8B CHF | 5.5 | 56.3 | 19.3 | 28.4 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.6B USD | 7 | 33.7 | 23.6 | 26.2 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.4B USD | 8.9 | 44.4 | 30.4 | 36.3 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
24.6B USD | 3 | 40.2 | 17.1 | 26.7 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
18.7B EUR | 6.9 | 73.5 | 31.7 | 52 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
